Ambulatory Surgery Centers Market Size, Share & Growth Report, 2033
The global ambulatory surgery centers market size was estimated at USD 124.44 billion in 2023 and is projected to hit around USD 226.89 billion by 2033, growing at a CAGR of 6.19% during the forecast period from 2024 to 2033.
The Ambulatory Surgery Centers (ASC) market has emerged as a critical component of modern healthcare delivery systems, offering patients a cost-effective and efficient alternative to traditional inpatient hospital care. These centers are medical facilities that specialize in performing same-day surgical procedures that do not require hospital admission. With the rising demand for minimally invasive surgeries, improved recovery times, and increased cost savings, ASCs are playing an increasingly vital role in healthcare infrastructure globally.
The ASC model is built on efficiency. It minimizes hospital-associated costs while optimizing patient throughput and satisfaction. This has led to a shift in the delivery of outpatient care, particularly in developed economies where reimbursement policies and insurance models increasingly favor outpatient interventions. Technological advancements in surgical techniques, anesthesia, and post-operative care have also allowed a broader range of procedures to be performed safely in ambulatory settings.
In recent years, the global ASC market has experienced consistent growth, driven by factors such as the aging population, increasing prevalence of chronic diseases, and the need for healthcare systems to manage costs while maintaining high-quality care. The market is becoming increasingly competitive with the entry of new players, including corporate chains and private equity-backed groups aiming to consolidate and expand ASC networks.
Expansion of Surgical Services: ASCs are now capable of performing more complex procedures including spine surgery and total joint replacements due to advances in surgical tools and patient monitoring systems.
Rising Prevalence of Chronic Conditions: An increase in diseases such as diabetes and arthritis fuels demand for frequent and affordable surgical interventions, which are often handled at ASCs.
Shift Towards Value-Based Care: Healthcare systems are transitioning from fee-for-service models to value-based care, making ASCs appealing for their cost transparency and outcome-focused services.
Technology Integration: Incorporation of advanced technologies such as robotic-assisted surgeries, AI in surgical planning, and telemedicine is enhancing the scope and safety of outpatient procedures.
Increased Corporate Investment: Large healthcare corporations and investment groups are acquiring or establishing ASCs to expand service offerings and achieve economies of scale.
COVID-19 Impact and Recovery: The pandemic temporarily disrupted ASC operations, but post-pandemic recovery has been strong as hospitals seek to reduce inpatient volumes and prioritize acute care.
Regulatory Support: Reimbursement and policy changes by agencies like CMS (Centers for Medicare & Medicaid Services) in the U.S. are expanding the list of ASC-eligible procedures.
| Report Attribute | Details |
| Market Size in 2024 | USD 132.15 Billion |
| Market Size by 2033 |
USD 226.89 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 6.19% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Application, ownership, center type, region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | CHSPSC, LLC.; Envision Healthcare Corporation; TH Medical; Pediatrix Medical Group; UNITEDHEALTH GROUP; Surgery Partners; Healthway Medical Group; SurgCenter; Prospect Medical Holdings, Inc.; Group Eifelhöhen-Klinik AG; Edward-Elmhurst Health; Nexus Day Surgery Centre |
A significant driver for the ASC market is the substantial cost savings associated with performing surgeries in outpatient settings compared to inpatient hospitals. On average, surgical procedures in ASCs can be 30% to 50% cheaper, which is particularly appealing to insurers and patients with high-deductible plans. With rising healthcare expenditures globally, payers—both public and private—are under pressure to find sustainable models of care that offer quality outcomes at reduced costs.
For example, a knee arthroscopy procedure in a hospital may cost over $5,000, whereas the same procedure at an ASC could cost under $3,000. The cumulative impact of such savings is significant for healthcare systems dealing with millions of procedures annually. Additionally, the bundled payment models and transparency in billing practices at ASCs enhance their attractiveness for patients and payers alike.
One major restraint for the growth of ASCs is their limited capacity to manage surgical complications or emergencies. Unlike hospitals, ASCs typically do not have emergency departments or intensive care units on standby. This makes them unsuitable for high-risk or emergency surgeries, limiting their scope.
Moreover, patients with comorbid conditions may face higher surgical risks that require immediate intervention, making hospital settings more appropriate. Regulatory bodies also impose strict licensing and accreditation requirements, which can be a barrier for new ASCs entering the market. These limitations may also contribute to hesitancy among some patients and providers in choosing ASCs for more complex procedures.
The global rise in the geriatric population presents a significant opportunity for the ASC market. As individuals age, they are more likely to require surgeries such as cataract removal, joint replacements, colonoscopies, and ENT procedures—many of which can be performed in ASCs. According to the World Health Organization, the number of people aged 60 and above will rise to 2.1 billion by 2050.
This aging demographic is more susceptible to chronic and degenerative diseases, thereby increasing the demand for surgical interventions. The convenience, shorter recovery times, and lower costs associated with ASCs make them a preferable choice for elderly patients and caregivers. Furthermore, ASCs can offer specialized geriatric care models that cater to mobility, post-operative recovery, and pain management needs in this population segment.
Orthopedics dominated the ASC market by application. The orthopedic segment holds the lion’s share due to the rising prevalence of musculoskeletal conditions and the shift toward minimally invasive orthopedic procedures such as arthroscopy and joint repair. Procedures such as ACL reconstruction, rotator cuff repair, and total joint arthroplasty are increasingly performed in ASCs. The use of robotics and image-guided surgical systems is also contributing to the rising preference for orthopedic surgeries in ambulatory settings. Moreover, orthopedic ASCs are designed to accommodate these procedures with advanced surgical suites and post-op recovery facilities.
The pain management/spinal injections segment is the fastest-growing due to the increasing burden of chronic back and neck pain across all age groups. With the rise of sedentary lifestyles, desk-bound jobs, and stress-related health issues, spinal disorders have become more prevalent. Epidural injections, nerve blocks, and other pain-relieving interventions are increasingly being handled in ASCs, which offer convenience and repeated access to care. The ongoing opioid crisis in many countries has also accelerated the demand for interventional pain procedures, positioning this segment for rapid growth.
Physician-owned ASCs dominated the market in terms of ownership. These facilities are often independently operated or run in small groups and are known for high levels of physician engagement and patient-centric care. Physicians often have a direct financial stake, which encourages greater operational efficiency and attention to quality outcomes. These centers benefit from physician referrals and tend to focus on specialized procedures that reflect the physician's expertise.
The corporate-owned segment is the fastest-growing. The increasing involvement of large hospital networks, investment firms, and healthcare conglomerates is reshaping the ASC landscape. Corporates are leveraging scale, technology, and administrative capabilities to open new centers or acquire existing ones. The goal is to create a network of standardized, scalable ASCs that deliver consistent care quality and revenue. This segment is expected to grow significantly, particularly in North America and emerging markets.
Multi-specialty ASCs dominated the market based on center type. These centers offer a wide range of services under one roof, which appeals to both patients and providers. The flexibility in scheduling, shared overhead costs, and the ability to perform various procedures make multi-specialty ASCs financially viable and operationally efficient. They also attract patients looking for convenient, one-stop healthcare solutions.
Single-specialty ASCs are the fastest-growing, particularly in ophthalmology, orthopedics, and pain management. These centers are built around a focused set of procedures, allowing them to streamline operations, reduce costs, and enhance surgical outcomes. With the growing trend of niche-specialization and subspecialty care, many providers are opening single-specialty centers to deliver highly efficient, volume-driven surgical services.
North America, particularly the United States, is the leading region in the ASC market. This dominance can be attributed to the country’s advanced healthcare infrastructure, favorable reimbursement policies, and the presence of numerous ASC chains. The U.S. has over 5,000 ASCs, and the number is rising steadily. The Centers for Medicare & Medicaid Services has played a critical role by expanding the list of approved ASC procedures and implementing value-based reimbursement models.
The high prevalence of chronic diseases, coupled with increasing consumer awareness and demand for convenience, has bolstered ASC usage across states. Moreover, insurance providers and employers prefer ASCs for cost-control, contributing to their market leadership. Leading companies like SCA Health (a UnitedHealth Group company), AmSurg, and HCA Healthcare operate extensive ASC networks across the region.
Asia-Pacific is the Fastest-Growing Region
Asia-Pacific is emerging as the fastest-growing region in the ASC market. The growth is fueled by rising healthcare expenditure, improving infrastructure, and increasing government support for outpatient care services in countries like India, China, and Japan. As the region undergoes rapid urbanization and economic development, access to quality healthcare services is expanding beyond metropolitan areas.
In India, for instance, private healthcare providers are setting up day-care surgical centers to cater to the growing middle-class population that seeks cost-effective and timely surgical care. Similarly, China's push towards healthcare reforms and its aging population are boosting demand for outpatient surgeries. Additionally, medical tourism is driving growth in this region, as international patients seek high-quality surgical care at lower costs in countries like Thailand, Malaysia, and South Korea.
The market is competitive owing to the presence of several ambulatory surgery center providers. Market players are adopting various strategies, such as new service launches, partnerships & collaborations, and regional expansion to gain higher shares. For instance, in February 2023, Spire Orthopedic Partners partnered with Dutchess County Orthopedic Associates, making Spire one of the largest orthopedic platforms in the United States. This will enable the company to serve existing patients better and meet the increasing demand.
In July 2022, the Southeastern Spine Institute Ambulatory Surgery Center, an affiliate of United Surgical Partners International, introduced a robotic surgery program. The center is equipped with advanced robotic systems to improve the accuracy and effectiveness of total knee replacement surgery. Additionally, in January 2022, ValueHealth LLC announced that its JV partner Penn State Health had acquired shares in the Surgery Center of Lancaster.Some of the prominent players in the global ambulatory surgery centers market include:
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the Ambulatory Surgery Centers market.
By Application
By Ownership
By Center Type
By Region
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers